Valeant Pharmaceuticals International, Inc. today announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P.

Better environmental DNA tests could help scientists save endangered species and find invasive ones.

Leidos (NYSE: LDOS), a global science and technology company, was awarded a task order from the U.S. Army to integrate, test and demonstrate the three complete Airborne Reconnaissance Low-Enhanced (ARL-E) systems under the ARL-E program of record

Roche announced today that OCREVUS® (ocrelizumab) has been approved by the Australian Therapeutic Goods Administration (TGA) for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS)